Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novartis
Novartis
Novartis gets European approval for Afinitor
Marketwatch
Tue, 09/6/11 - 11:46 am
Novartis
Europe
Afinitor
The Big Bet on YM BioSciences
Motley Fool
Thu, 09/1/11 - 12:14 pm
YM BioSciences
myelofibrosis
ruxolitinib
CYT387
Novartis
Incyte
Roche to maintain lead in targeted drugs
Yahoo/Reuters
Wed, 08/31/11 - 12:55 pm
Roche
targeted therapeutics
Novartis
Pfizer
FDA asks Novartis for more data on gout drug
Reuters
Mon, 08/29/11 - 01:11 pm
gout
FDA
Novartis
Ilaris
10 Most Popular Drug Companies That Hedge Funds Love
Seeking Alpha
Sat, 08/27/11 - 01:06 pm
JNJ
Pfizer
Sanofi
Merck
Abbott Laboratories
Bristol-Myers Squibb
Eli Lilly
Novartis
Impax Labs
Anthera
Bone drug tied to lower colon cancer risk
Yahoo/Reuters
Tue, 08/23/11 - 08:26 am
colon cancer
biophosphonates
Merck
Fosamax
Roche
Boniva
Novartis
Reclast
Actonel
Warner Chilcott
Sandoz Sues Novo Nordisk to Head Off Generic Challenge on Diabetes Drug
Bloomberg
Fri, 08/19/11 - 11:15 am
Sandoz
Prandin
Novo Nordisk
Novartis
generics
diabetes
Top 10 Biotech Companies to Buy to Beat the Down Economy
Seeking Alpha
Thu, 08/18/11 - 05:33 pm
Abbott Laboratories
Amgen
Bristol-Myers Squibb
GSK
Jazz Pharmaceuticals
Eli Lilly
Merck
Novartis
Pfizer
Questcor Pharmaceuticals
8 Defensive High-Yield Pharmaceuticals to Consider
Seeking Alpha
Thu, 08/18/11 - 12:29 pm
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
JNJ
Novartis
Pfizer
Sanofi
Sector Snap: Analyst sees pharma as 'safe haven'
Yahoo/AP
Sat, 08/13/11 - 02:57 pm
Pfizer
Bayer
Novartis
AstraZeneca
Novo Nordisk
Awaiting Novartis acquisition, biotech firm Proteon raises $15.2M
Bizjournals.com
Fri, 08/12/11 - 09:33 am
Novartis
Proteon
M&A
JNJ and GSK Lead Market Action in Healthcare Sector August 11th
Yahoo/Wall St. Cheat Sheet
Fri, 08/12/11 - 08:30 am
JNJ
GSK
Novartis
Pfizer
Merck
Sanofi
Abbott Laboratories
AstraZeneca
Novo Nordisk
Amgen
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
Drug Maker Dividend Stocks With Strong Growth Prospects
Seeking Alpha
Wed, 08/10/11 - 10:47 am
Pfizer
Merck
Bristol-Myers Squibb
Novartis
Takeda
Sanofi
Eli Lilly
GSK
Roche
AstraZeneca
dividends
U.K. rejects MS drug over cost
Yahoo/Investor's Business Daily
Sat, 08/6/11 - 01:26 pm
Novartis
multiple sclerosis
Gilenya
Novartis’s Jimenez Has Blockbuster Plans for Diovan After Patent Expires
Bloomberg
Fri, 08/5/11 - 11:46 am
Diovan
Novartis
Joe Jimenez
Merck, Novartis top drug-approval rankings
Fierce Pharma
Thu, 08/4/11 - 10:20 am
drug approvals
Merck
Novartis
Key blockbuster drugs about to get generic rivals
Yahoo/AP
Mon, 07/25/11 - 09:10 am
generics
Eli Lilly
Forest Labs
Pfizer
AstraZeneca
Cephalon
Bristol-Myers Squibb
Sanofi
patents
Abbott Laboratories
Merck
Takeda
Novartis
Endo
GSK
Report Fuels Titan Pharmaceuticals Take Over Speculation
Seeking Alpha
Thu, 07/21/11 - 02:02 pm
M&A
Titan
Novartis
Vanda
FDA Reviewing Osteoporosis Drugs for Esophageal Cancer Risk
Bloomberg
Thu, 07/21/11 - 02:01 pm
FDA
osteoporosis
esophageal cancer
Roche
Novartis
bisphosphonates
Merck
Boniva
Reclast
Fosamax
Pages
« first
‹ previous
…
129
130
131
132
133
134
135
136
137
…
next ›
last »